Environmental Assessment for Investigational Use of Aedes Aegypti OX513A

U.S. Food and Drug Administration. 08/05/2016 This 138-page document provides information about the environmental review for a proposed field trial to determine whether the release of Oxitec Ltd. ' s genetically engineered mosquitoes (OX513A) will suppress the local Aedes aegypti mosquito population in the release area at Key Haven, Florida. This mosquito is known to transmit potentially debilitating human viral diseases, including Zika, dengue, yellow fever, and chikungunya. The environmental assessment concluded that the proposed field trial will not have significant impacts on the environment. (PDF)

Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - August 7, 2016 Category: Global & Universal Authors: The U.S. National Library of Medicine Source Type: news